Our faculty and researchers are at the forefront of research and have expertise in a range of areas, from health equity to chronic diseases.
We conduct research aimed at giving health care providers, consumers and policymakers the information they need for informed decision making, including:
Our faculty and researchers are actively engaged in cutting-edge research projects that aim to improve patient outcomes, inform clinical practice, and shape healthcare policy. Explore our current research projects and learn more about the innovative work being conducted by our team.
This Centers for Disease Control and Prevention (CDC) funded project will use population data to examine factors leading to co-prescriptions of opioids and sedative medications which pose higher risk of overdose.
Stigma against those who use substances, from healthcare professionals, family, friends, the general community, and even themselves, is considered to be a major barrier to successful engagement in treatment. This project focuses on how to measure stigma among substance users and how to change it.
EnROUTE is a mixed methods study designed to integrate patient, provider, and community perspectives with epidemiologic data to address transportation insecurity in patients with end stage kidney disease (ESKD) treated with in-center hemodialysis.
New Department of Family and Community Medicine research faculty member Dr. Adeola Oni-Orisan has been selected to the 2022-2023 cohort of the prestigious Center for the Advancement of Multicultural Perspectives on Science (CAMPOS) Faculty Scholars program! You can read more here: Meet the 2022 CAMPOS Faculty Scholars | Diversity, Equity & Inclusion (ucdavis.edu)
Dr. Joshua Fenton, co-investigator Dr. Alicia Agnoli and their team have received a new CDC research grant to study the risks of combined opioid and benzodiazepine therapy.
Dr. Elizabeth Magnan and colleagues from multiple UC campuses recently published a policy brief on the potential impacts, benefits and risks of universal screening for adverse childhood events (ACEs) among children and adults. This work arose from a bill analysis they conducted for the California State Legislature last year as part of the California Health Benefits Review Program (CHBRP). The brief may be read here.
Dr. Mika Godzich, DFCM Residency Director, was a co-author of “Mental health implications of abortion restrictions for historically marginalized populations,” in New England Journal of Medicine. Dr. Godzich and colleagues review the implications of the Supreme Court’s Dodd decision through an intersectional lens that takes in structural racism, reproductive injustice, and mental health.
Dr. Alicia Agnoli, whose lead author paper previously published in JAMA, entitled “Association of Dose Tapering with Overdose or Mental Health Crisis Among Patients Prescribed Long-Term Opioids,” received Distinguished Clinical Research Achievement Award at the 2022 Clinical Research Forum in Chicago. Dr. Agnoli’s was one of the Top 3 papers at the meeting (out of 10 finalists). Her DFCM co-authors were Drs. Beth Magnan, Anthony Jerant, and Joshua Fenton.